| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |